相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study
Steven W. Pipe et al.
LANCET HAEMATOLOGY (2019)
Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein
J. Oldenburg et al.
HAEMOPHILIA (2018)
The socioeconomic burden of patients affected by hemophilia with inhibitors
Lucia S. D'Angiolella et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
J. Mahlangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Immunogenicity of Emicizumab in People with Hemophilia A (PwHA): Results from the HAVEN 1-4 Studies
Ido Paz-Priel et al.
BLOOD (2018)
Early Prophylaxis Provides Continued Joint Protection in Severe Hemophilia A: Results of the Joint Outcome Continuation Study
Beth Boulden Warren et al.
BLOOD (2018)
A Pharmacometric Approach to Substitute for a Conventional Dose-Finding Study in Rare Diseases: Example of Phase III Dose Selection for Emicizumab in Hemophilia A
Koichiro Yoneyama et al.
CLINICAL PHARMACOKINETICS (2018)
Emicizumab Prophylaxis in Hemophilia A with Inhibitors
Johannes Oldenburg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
When and how to start prophylaxis in boys with severe hemophilia without inhibitors: communication from the SSC of the ISTH
K. Fischer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Impact of inhibitors on hemophilia A mortality in the United States
Christopher E. Walsh et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A
Thierry Calvez et al.
BLOOD (2014)
Randomized comparison of prophylaxis and on-demand regimens with FEIBA NF in the treatment of haemophilia A and B with inhibitors
S. V. Antunes et al.
HAEMOPHILIA (2014)
Definitions in hemophilia: communication from the SSC of the ISTH
V. S. Blanchette et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Guidelines for the management of hemophilia
A. Srivastava et al.
HAEMOPHILIA (2013)
Factor VIII Products and Inhibitor Development in Severe Hemophilia A
Samantha C. Gouw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
DEVELOPMENT OF AN INHIBITOR-SPECIFIC QUESTIONNAIRE FOR THE ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN HAEMOPHILIA PATIENTS WITH INHIBITORS (INHIB-QOL)
S. Von Mackensen et al.
VALUE IN HEALTH (2013)
The principal results of the International Immune Tolerance Study: a randomized dose comparison
Charles R. M. Hay et al.
BLOOD (2012)
How to manage invasive procedures in children with haemophilia
Rolf C. R. Ljung et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management
L. A. Valentino et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model
Takehisa Kitazawa et al.
NATURE MEDICINE (2012)
PRO-PACT: Retrospective observational study on the prophylactic use of recombinant factor VIIa in hemophilia patients with inhibitors
Guy Young et al.
THROMBOSIS RESEARCH (2012)
Anti-Inhibitor Coagulant Complex Prophylaxis in Hemophilia with Inhibitors
Cindy Leissinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs
E. Santagostino et al.
HAEMOPHILIA (2009)
Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors
B. A. Konkle et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
Marilyn J. Manco-Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study
Samantha C. Gouw et al.
BLOOD (2007)
The Haemo-QoL Index:: developing a short measure for health-related quality of life assessment in children and adolescents with haemophilia
E. Pollak et al.
HAEMOPHILIA (2006)
Central venous access devices in haemophilia
LA Valentino et al.
HAEMOPHILIA (2004)
分享论文
